1. Home
  2. Live Updates
  3. First-in-Disease Use of Kyverna Therapeutics' KYV-101 in Pat

First-in-Disease Use of Kyverna Therapeutics' KYV-101 in Pat

First-in-Disease Use of Kyverna Therapeutics' KYV-101 in Patients With Progressive Multiple Sclerosis Published in Med

First-in-Disease Use of Kyverna Therapeutics' KYV-101 in Patients With Progressive Multiple Sclerosis Published in Med

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Hamburg , Germany , United States , Eppendorf , Nordrhein Westfalen , Peter Maag , Christoph Heesen , University Medical Center Hamburg , National Institutes Of Health , Department Of Stem Cell Transplantation , Kyverna Therapeutics Inc , Kyverna Therapeutics , University Medical Center Hamburg Eppendorf , Stem Cell Transplantation , Northern European , National Institutes , Media Contact , Nature Medicine ,